These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 323732)

  • 1. [Experiences with sodium 2-propyl valerate (Depakine) in the treatment of epilepsy].
    Trompetter-van Woerden ML; van der Zwan A
    Ned Tijdschr Geneeskd; 1977 Apr; 121(14):578-90. PubMed ID: 323732
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of combination of valproic acid with diphenylhydantoin and carbamazepine in the management of intractable seizures.
    Ashok PP; Maheshwari MC
    J Assoc Physicians India; 1984 Jul; 32(7):565-7. PubMed ID: 6438054
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sodium di-n-propylacetate, effect in the treatment of resistant epilepsy. A controlled study].
    Gram L; Wulff K; Rasmussen KE; Flachs H; Würtz-Jørgensen A; Sommerbeck KW; Løhren V
    Ugeskr Laeger; 1977 May; 139(18):1064-9. PubMed ID: 324058
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the effectiveness of monotherapy in the treatment of epilepsy].
    Brignolio F; Verzè L; Baruchello M
    Minerva Med; 1991 Dec; 82(12):859-62. PubMed ID: 1780094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Trial of a new antiepileptic drug, magnesium dipropyl acetate].
    de Pasquet EG; Gomensoro JB; de Bustos LF; Tenzer SM
    Acta Neurol Latinoam; 1973; 19(1-4):119-28. PubMed ID: 4619958
    [No Abstract]   [Full Text] [Related]  

  • 6. Valproate sodium: a controlled clinical trial including monitoring of drug levels.
    Gram L; Wulff K; Rasmussen KE; Flachs H; Würtz-Jorgensen A; Sommerbeck KW; Lohren V
    Epilepsia; 1977 Jun; 18(2):141-8. PubMed ID: 326542
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sodium di-n-propylacetate: evaluation of its so-called psychotropic effect. A controlled study].
    Sommerbeck KW; Theilgaard A; Rasmussen KE; Løhren V; Gram L; Wulff K
    Ugeskr Laeger; 1977 May; 139(18):1069-73. PubMed ID: 324059
    [No Abstract]   [Full Text] [Related]  

  • 8. Controlled trial of sodium valproate in severe epilepsy.
    Richens A; Ahmad S
    Br Med J; 1975 Nov; 4(5991):255-6. PubMed ID: 1104059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of ergenyl (dipropylacetate) in hypsarrhythmia].
    Rohmann E; Arndt R
    Kinderarztl Prax; 1976 Mar; 44(3):109-13. PubMed ID: 775170
    [No Abstract]   [Full Text] [Related]  

  • 10. [Double-blind study on the anti-convulsive effect of phenobarbital and valproate in the Lennox syndrome].
    Vassella F; Rüdeberg A; Da Silva V; Pavlincova E
    Schweiz Med Wochenschr; 1978 May; 108(19):713-6. PubMed ID: 347569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modification of personality changes in epileptics using dipropylacetate (Convulex). Preliminary communication].
    Deisenhammer E
    Wien Med Wochenschr; 1977 Jun; 127(12):370-3. PubMed ID: 333779
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium valproate in the treatment of childhood epilepsies.
    Maheshwari MC
    Indian Pediatr; 1984 Jun; 21(6):439-46. PubMed ID: 6439636
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug resistant epilepsy in Senegal: therapeutic, clinical and socioeconomic factors].
    Gueye L; Sene MC; Sene F; Mesdjian E; Farnarier G; Diagne M; Ndiaye IP
    Dakar Med; 1999; 44(1):1-7. PubMed ID: 10797976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: Sodium valproate in the treatment of intractable childhood epilepsy.
    Coulthard MG
    Dev Med Child Neurol; 1975 Aug; 17(4):534. PubMed ID: 1098952
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of antiepileptic drugs on sleep patterns.
    Declerck AC; Wauquier A
    Epilepsy Res Suppl; 1991; 2():153-63. PubMed ID: 1684711
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlled and comparative trials with valproate: United States.
    Ramsay RE
    Epilepsia; 1984; 25 Suppl 1():S40-3. PubMed ID: 6425045
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum aspirin-esterase activity in epileptic patients receiving treatment with phenobarbital, phenytoin, carbamazepine and valproic acid.
    Puche E; Garcia de la Serrana H; Mota C; Saucedo R
    Int J Clin Pharmacol Res; 1989; 9(1):55-8. PubMed ID: 2496043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium valproate (Epilim) in the treatment of refractory epilepsy.
    Lines DR
    N Z Med J; 1978 Jan; 87(603):9-12. PubMed ID: 347342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A correlation between the levels of phenobarbital, phenytoin and valproic acid in the blood serum and in saliva from children treated due to epilepsy.
    Sobaniec W
    Mater Med Pol; 1989; 21(4):323-6. PubMed ID: 2489248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.